These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 24106397)

  • 1. Probiotics and irritable bowel syndrome.
    Dai C; Zheng CQ; Jiang M; Ma XY; Jiang LJ
    World J Gastroenterol; 2013 Sep; 19(36):5973-80. PubMed ID: 24106397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal microbiota in pathophysiology and management of irritable bowel syndrome.
    Lee KN; Lee OY
    World J Gastroenterol; 2014 Jul; 20(27):8886-97. PubMed ID: 25083061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last?
    Bixquert Jiménez M
    Rev Esp Enferm Dig; 2009 Aug; 101(8):553-64. PubMed ID: 19785495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irritable bowel syndrome: the evolution of multi-dimensional looking and multidisciplinary treatments.
    Chang FY
    World J Gastroenterol; 2014 Mar; 20(10):2499-514. PubMed ID: 24627587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling the ties between irritable bowel syndrome and intestinal microbiota.
    Hong SN; Rhee PL
    World J Gastroenterol; 2014 Mar; 20(10):2470-81. PubMed ID: 24627584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
    Barbara G; Zecchi L; Barbaro R; Cremon C; Bellacosa L; Marcellini M; De Giorgio R; Corinaldesi R; Stanghellini V
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis.
    Didari T; Mozaffari S; Nikfar S; Abdollahi M
    World J Gastroenterol; 2015 Mar; 21(10):3072-84. PubMed ID: 25780308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized double-blind placebo-controlled clinical trial on efficacy and safety of association of simethicone and Bacillus coagulans (Colinox®) in patients with irritable bowel syndrome.
    Urgesi R; Casale C; Pistelli R; Rapaccini GL; de Vitis I
    Eur Rev Med Pharmacol Sci; 2014; 18(9):1344-53. PubMed ID: 24867512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment.
    Parkes GC; Brostoff J; Whelan K; Sanderson JD
    Am J Gastroenterol; 2008 Jun; 103(6):1557-67. PubMed ID: 18513268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
    Harris LA; Baffy N
    Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is irritable bowel syndrome an infectious disease?
    Thompson JR
    World J Gastroenterol; 2016 Jan; 22(4):1331-4. PubMed ID: 26819502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets.
    Dupont HL
    Aliment Pharmacol Ther; 2014 May; 39(10):1033-42. PubMed ID: 24665829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of commensals and probiotics on visceral sensitivity and pain in irritable bowel syndrome.
    Theodorou V; Ait Belgnaoui A; Agostini S; Eutamene H
    Gut Microbes; 2014; 5(3):430-6. PubMed ID: 25184834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating irritable bowel syndrome with probiotics: the evidence.
    Parkes GC; Sanderson JD; Whelan K
    Proc Nutr Soc; 2010 May; 69(2):187-94. PubMed ID: 20236566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotics, Prebiotics, and Synbiotics: Implications and Beneficial Effects against Irritable Bowel Syndrome.
    Simon E; Călinoiu LF; Mitrea L; Vodnar DC
    Nutrients; 2021 Jun; 13(6):. PubMed ID: 34203002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal microbiota and its role in irritable bowel syndrome (IBS).
    Ohman L; Simrén M
    Curr Gastroenterol Rep; 2013 May; 15(5):323. PubMed ID: 23580243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options.
    Konturek PC; Brzozowski T; Konturek SJ
    J Physiol Pharmacol; 2011 Dec; 62(6):591-9. PubMed ID: 22314561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotics in Irritable Bowel Syndrome: The Science and the Evidence.
    Quigley EM
    J Clin Gastroenterol; 2015; 49 Suppl 1():S60-4. PubMed ID: 26447967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irritable bowel syndrome: a concise review of current treatment concepts.
    Wall GC; Bryant GA; Bottenberg MM; Maki ED; Miesner AR
    World J Gastroenterol; 2014 Jul; 20(27):8796-806. PubMed ID: 25083054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging Role of the Gut Microbiome in Irritable Bowel Syndrome.
    Singh P; Lembo A
    Gastroenterol Clin North Am; 2021 Sep; 50(3):523-545. PubMed ID: 34304786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.